AIM
CCRN icon

Aigen Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Aigen Investment Management’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,425
Closed -$462K – 703
2023
Q4 		$462K Buy
20,425
+11,604
+132% +$252K 0.08% 354
2023
Q3 		$219K Buy
+8,821
New +$222K 0.04% 644
2022
Q4 		– Sell
-19,069
Closed -$541K – 552
2022
Q3 		$541K Buy
+19,069
New +$490K 0.08% 295
2021
Q2 		– Sell
-17,415
Closed -$218K – 498
2021
Q1 		$218K Sell
17,415
-158
-0.9% -$1.68K 0.03% 519
2020
Q4 		$156K Sell
17,573
-553
-3% -$4.5K 0.02% 706
2020
Q3 		$118K Buy
18,126
+331
+2% +$2.1K 0.02% 708
2020
Q2 		$110K Buy
17,795
+13,675
+332% +$83.9K 0.01% 755
2020
Q1 		$28K Buy
4,120
+2,108
+105% +$20K ﹤0.01% 1053
2019
Q4 		$23K Buy
+2,012
New +$22.7K ﹤0.01% 897

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aigen Investment Management's CCRN Position: Q1 2024 in Review

Aigen Investment Management sold out of Cross Country Healthcare (CCRN) in Q1 2024, closing a stake of 20,425 shares — an estimated $462K sold.

Aigen Investment Management first reported a position in CCRN in Q4 2019 and held it in 9 quarters. The position peaked at $541K in Q3 2022. 175 funds tracked by Wall St. Rank hold CCRN as of Q1 2024.

  • Aigen Investment Management reported no remaining Cross Country Healthcare position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 20,425 Cross Country Healthcare shares in Q1 2024, an estimated $462K.
  • Aigen Investment Management first reported a position in Cross Country Healthcare in Q4 2019 and held it in 9 quarters.
  • Aigen Investment Management's Cross Country Healthcare position peaked at $541K in Q3 2022.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.